A year of unprecedented growth

Waters’ revenue for the FY14-15 crossed the Rs 700 crore mark and stood at Rs 722.66 crore, making it the No.2 BioSupplier


Rank: 2
Organization: Waters India Pvt Ltd
President: Mr KV Venugopalan
Revenue: Rs 722.66 crore


Waters clocked a turnover of whooping Rs 722.66 crore in the financial year 2014-15, an increase of about 28 percent in its revenue from the previous fiscal's Rs 564.38 crore. The company says the LC instrumentation business contributed to the major chunk of its business in India, while mass spectrometry uptake also jumped in sales. On a global basis biopharma sector showed a strong growth across product-lines sold to biopharma market.

In one of the major deals in the last fiscal, Waters Corporation and Tecan Group entered into an agreement to combine Tecan's Freedom EVO liquid handling platform with Waters ACQUITY TQD liquid chromatograph/ mass spectrometer (LC/MS/MS) to automate sample preparation. Waters will combine the technologies from both companies into a single, fully-supported analytical system solution that helps laboratories increase assay throughput and efficiency, improve profitability, and drive down overall assay costs.

During the last fiscal year, the firm unveiled a wide range of innovative products catering to the major disciplines of lifesciences. The firm's latest offerings include Xevo G2-XS QTof and Xevo TQ-S micro Mass Spectrometers, taking Benchtop Quantitative and Qualitative MS Applications to New Levels. It also added the SYNAPT G2-Si to its mass spectrometer product line. In the chromatography segment, the firm introduced the ACQUITY QDa Detector, bringing push-button mass detection to chromatography.

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email